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Artificial intelligence has been defined as “the part of digital 
technology that denotes the use of coded computer software 
routines with specific instructions to perform tasks for which 
a human brain is normally considered necessary.”1 The most 
complex connotation of the term artificial intelligence, that of 
machines with human-like general intelligence, is still a distant 
vision. However, artificial intelligence in the more restricted 
sense defined above is already broadly embedded in society 
in a variety of forms. The pace of development of new and 
improved artificial intelligence-based technologies is rapid; 
the question is no longer whether artificial intelligence will 
have an impact, but “by whom, how, where, and when this 
positive or negative impact will be felt.”2
Many areas of health care could benefit from the use 
of artificial intelligence technology. According to a recent 
literature review, artificial intelligence is already being used: 
“(1) in the assessment of risk of disease onset and in estimat-
ing treatment success [before] initiation; (2) in an attempt to 
manage or alleviate complications; (3) to assist with patient 
care during the active treatment or procedure phase; and (4) in 
research aimed at elucidating the pathology or mechanism of 
and/or the ideal treatment for a disease.”3 On the risk side, 
others have summarized several health-related concerns: the 
potential for bias in the data used to train artificial intelligence 
algorithms; the need for protection for patients’ privacy; po-
tential mistrust of digital tools by clinicians and the general 
public; and ensuring health-care personnel handle artificial 
intelligence in a trustworthy manner.4 Other concerns relate 
to physical applications of artificial intelligence. For example, 
while robots could be useful in the care of the elderly, there 
are risks of reduced contact between humans, the deception 
of encouraging companionship with a machine and loss of 
control over a person’s own life.5 Questions have also been 
raised about the extent to which artificial intelligence technolo-
gies could replace clinicians6 and, if so, whether the opacity 
of machine learning-based decisions weaken the authority of 
clinicians, threaten patients’ autonomy7 or jeopardize shared 
decision-making between doctor and patient.8
Discussions of the risks posed by artificial intelligence 
systems range from current concerns, such as violations of 
privacy or harmful effects on society, to debates about whether 
machines could ever escape from human control. However, 
fully predicting the consequences of these technological de-
velopments is not possible. The need for a precautionary ap-
proach to artificial intelligence highlights the importance of 
thoughtful governance. By applying our human intelligence, 
we have the opportunity, through control of decision-making, 
to steer the development of artificial intelligence in ways that 
accord with human values and needs.
Guidance has been developed through initiatives that aim 
to foster responsible and trustworthy artificial intelligence 
and to mitigate unwanted consequences. Examples include 
AI4People,2 Asilomar AI principles9 and the Montreal Declara-
tion for a Responsible Development of Artificial Intelligence.10 
In this paper we focus on the report of the independent High-
Level Expert Group on Artificial Intelligence set up by the 
European Commission.11 Ethical guidelines for trustworthy 
AI identified trustworthy artificial intelligence as consisting 
of three components: (i) compliance with all applicable laws 
and regulations; (ii) adherence to ethical principles and values; 
and (iii) promotion of technical and societal robustness. These 
components are important throughout the cycle of develop-
ment, deployment and use of artificial intelligence. 
The expert group’s report focuses on the ethics and ro-
bustness of artificial intelligence rather than the legal issues, 
basing ethical guidance for trustworthy artificial intelligence 
on a fundamental rights approach.11 Four principles rooted in 
these fundamental rights shape the framework and are trans-
lated into more specific requirements: (i) respect for human 
autonomy; (ii) prevention of harm; (iii) fairness; and (iv) ex-
plicability (the report stresses that this list is not necessarily 
exhaustive). These requirements can translate into a tailored 
list to allow for assessments of specific artificial intelligence 
interventions (Fig. 1). The first three principles are well-estab-
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lished in the bioethical literature.12 The 
principle of explicability is intended to 
gain an understanding of how artificial 
intelligence generates output, which is 
important for contesting decisions based 
on artificial intelligence and tracing ap-
propriate chains of accountability.2
These general ethical principles 
may, however, conflict with each other. 
Any conflicts should be managed by 
deliberations that are accountable to 
and conditioned by democratic systems 
of public engagement and processes of 
open political participation.11 The expert 
group’s report strongly emphasized the 
need for responsible governance and 
the role of stakeholders “including the 
general public.” The safety mechanisms 
proposed include a “basic artificial intel-
ligence literacy [that] should be fostered 
across society.” Building trustworthiness 
into artificial intelligence therefore 
relies on assumptions about a high-
functioning, deliberative democracy 
and its governing potential to drive the 
development of artificial intelligence-
based technologies. The expert group 
also highlighted the context-specific 
nature of artificial intelligence (“differ-
ent situations raise different challenges”) 
and the need for an additional sectoral 
approach to the general framework 
they propose. As part of a coordinated 
artificial intelligence strategy for the 
European Commission and European 
Union (EU) Member States, the report’s 
recommendations are expected to be 
central in shaping the development and 
use of artificial intelligence in Europe. 
Since the use and impact of artificial 
intelligence spans national borders, the 
expert group calls for work towards a 
global ethical guidance.11 We believe 
that the ethical concerns and challenges 
addressed by the EU’s framework have 
global relevance. Basing the principles 
on a fundamental rights approach means 
that their relevance and significance can 
be considered universal. Indeed, the 
principles are rooted in the same rights 
and obligations that structure most of 
the United Nations’ (UN) sustainable 
development goals (SDGs) and that 
influence development strategies in low-
and middle-income countries beyond 
the EU. Thus, the content of the ethical 
framework (principles and guidelines) 
fronted by the expert group can be 
expected to carry legitimacy across 
cultural contexts and economic divides. 
The risks and potential negative impact 
artificial intelligence systems can have, 
for example “on democracy, the rule 
of law and distributive justice, or on 
the human mind”11 are also applicable 
wherever such institutions are in place.
The EU expert group’s framework 
is a process of first identifying fun-
damental ethical principles that are 
acknowledged through public debate as 
relevant for different contexts and across 
domains of analysis and then translating 
these principles into “viable guidelines 
to shape artificial intelligence-based 
innovation.”13 However, while an ethical 
framework can recommend a process for 
how to resolve conflicting ethical prin-
ciples in real-world situations, it cannot 
provide concrete, practical solutions 
for specific contexts. Moreover, ethical 
frameworks may not provide guidance 
on how to deal with conflicts that can 
occur between realizing the aim of the 
framework itself (such as ethically justi-
fied artificial intelligence) and realiza-
tion of other goods (such as economic 
growth or achieving the SDGs). In the 
following section, we discuss how such 
conflicts occur in the health-care arena 
in ways that undermine the trustwor-
thiness assumed by the expert group’s 
framework. Finally, we outline how a 
global initiative emerging from within 
various sectors can constructively pro-
mote globally trustworthy applications 
of artificial intelligence.
Ethical challenges
Despite its global relevance, the EU 
expert group’s framework may fail to 
provide trustworthy safeguards for the 
use of artificial intelligence in all health 
settings. We reflect here on how gen-
eral, structural features of global health 
systems, general human motivation and 
known drivers of interest for actions 
might together impact on the develop-
ment and implementation of artificial 
intelligence systems. We have identified 
five areas of ethical concern: (i) conflict-
ing goals; (ii) unequal contexts; (iii) risk 
and uncertainty; (iv) opportunity costs; 
and (v) democratic deficits (Box 1). 
These distinct concerns, when com-
bined, demonstrate the need to foster 
trustworthy development, deployment 
and use of artificial intelligence as an 
explicitly global and transnational en-
deavour.
Conflicting goals
The health sector is affected by strong 
forces of global political governance, 
as exemplified by SDG 3 to: “ensure 
healthy lives and promote well-being 
for all ages,” and target 3.8 to: “achieve 
universal health coverage, including 
financial risk protection, access to 
quality essential health-care services 
and access to safe, effective, quality and 
affordable essential medicines and vac-
cines for all.”14 These global forces that 
shape local priority-setting in health 
care may, however, represent conflict-
ing goals. For example, the goals of 
equality of access to care and equality 
of care quality are not inherently con-
nected and can conflict with each other 
when implemented.15 Another example 
is the efficient use of resources when 
deciding what to include in universal 
health coverage. Governance of health 
care such that it meets all political and 
cost–effectiveness aims inevitably leads 
to trade-offs and priority-setting. Such 
trade-offs become more difficult when 
resources are scarcer.
Application of artificial intelligence 
can be more cost–effective than human 
labour. The call for cost–effective, un-
biased, equality-promoting solutions in 
the health sector can therefore be seen as 
an open invitation for constructive co-
Fig. 1. Framework for trustworthy artificial intelligence
Ethical principles
• Respect for human 
autonomy
• Prevention of harm
• Fairness
• Explicability
Requirements that capture ethical 
perspectives related to:
• Human agency and oversight
• Technical robustness and safety
• Privacy and data governance
• Transparency
• Diversity, non-discrimination and 
fairness




Tailored to specific artificial 
intelligence application
Source: Adapted from the report of the European Commission High-Level Expert Group on Artificial 
Intelligence.9
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operation with the artificial intelligence 
industry. Tools already being discussed 
include personal care robots,5 ambi-
ent assisted living technologies16 and 
humanoid nursing robots.17 A potential 
challenge, however, is that such ma-
chines might not be able to provide the 
same overall quality of care for everyone, 
as do interactions with human beings. 
Increasing accessibility by implement-
ing these more cost–effective methods 
will not solve the issue of equality if the 
quality of artificial intelligence-based 
interactions is worse than human in-
teractions.
Another consequence of striv-
ing to reach political goals needs to 
be addressed. The global challenge of 
achieving universal access to health 
care provides the artificial intelligence 
industry with an opportunity not only 
to promote a societal good, but also to 
make favourable investments. Yet if the 
profits are not fairly distributed, these 
investments will only benefit the artifi-
cial intelligence industry economically 
and thereby contribute to accumulated 
wealth for some. The inequalities in liv-
ing conditions that are associated with 
health inequalities may therefore persist 
or even worsen, thus undermining the 
political goal of ensuring healthy lives. 
Redistributing the economic benefits 
of large-scale investments in artificial 
intelligence in public health could be 
one way of compensating for the adverse 
determinants of health and therefore a 
strategy for promoting overall health 
equality. Transnational regulations are, 
however, required for such a redistribu-
tion to occur in a systematic manner 
within and across higher- and lower-
income countries.
Finally, the demand for policy de-
cisions in the health sector to be based 
on empirical evidence is also a force 
that may influence decisions to employ 
artificial intelligence technologies in 
the health-care sector and may distract 
from the risks associated with artificial 
intelligence technologies. The empiri-
cal evidence on which to base future 
risk calculations and assessments of 
new technologies may not be available 
before the opportunity to implement 
safeguards (such as regulations) has 
passed. Even when there are attempts 
to consider the uncertain, long-term 
impacts of artificial intelligence, the 
uncertain conclusions may be traded-off 
for clearly effective, short-term solutions 
to important problems.
Unequal contexts
The conditions in which people live, 
and therefore the determinants of their 
health, vary across countries. Many 
countries will struggle to find the re-
sources to address the SDGs and they 
will have to achieve the greatest possible 
health benefit out of the funds they have. 
In lower-income countries life expec-
tancy is increasing due to decreases in 
infectious diseases.18 The prevalence 
of noncommunicable diseases associ-
ated with older age will likely increase. 
Cost–effective artificial intelligence 
technologies that can help reach, screen, 
diagnose, prescribe treatment for and 
even care for such patients will be in-
valuable where there are insufficient re-
sources to increase the health workforce 
to meet the demographic challenge. 
On the other hand, in a high-income 
country with a well-developed, publicly 
funded health-care system introducing 
artificial intelligence-based methods to, 
for example, follow up the day-to-day 
social and nutritional care of elderly 
people could create other concerns. 
For example, the artificial intelligence 
system might replace an established, 
well-functioning workforce, which 
raises the concern that something valu-
able is lost in that transition. Unequal 
contextual factors create a different 
basis for the ethical assessment of the 
appropriateness of artificial intelligence. 
If applications of artificial intelligence 
actually provide poorer quality care 
for the elderly than does human intel-
ligence, then there is a risk of accepting 
different ethical standards for higher- 
and lower-income countries within the 
same ethical framework and thereby 
sustaining inequitable quality of health 
care across borders.
Risk and uncertainty
SDG 3 establishes an urgency to the 
goals of promoting health and reducing 
health inequalities, while measuring 
countries on how they perform con-
tributes another layer of motivation. 
Yet being willing to risk more to achieve 
aims to which strong values are attached 
creates a structural dilemma in the area 
of health and artificial intelligence eth-
ics. When resources are scarce, there 
might be a willingness to discount 
potential future harms. For example, 
implementing resource-efficient digital 
tools to monitor the movements of 
people with dementia could be seen as 
a step towards greater surveillance of 
society in the future. When people are 
in need of health care, concerns about 
the uncertain, potentially problematic, 
long-term impact of receiving help from 
an artificial intelligence-based system 
might not be their main priority. On a 
political level, precautionary thinking 
about highly uncertain future impacts 
may be ignored in favour of an effective 
solution, which helps to solve a national 
health challenge. Furthermore, toler-
ance towards the potential unwanted 
consequences of implementing artificial 
Box 1. Ethical challenges for the global development and implementation of artificial 
intelligence systems in health care
Conflicting goals
Forces, such as the economic interests of the artificial intelligence industry and the political 
objective of the United Nations’ sustainable development goals, can work against the promotion 
of ethically safe artificial intelligence technologies.
Unequal contexts
Unequal contextual factors across countries create different bases for the ethical assessment of 
acceptable employment of artificial intelligence and may thus sustain a non-universal standard 
and inequitable quality of health care across borders.
Risk and uncertainty
In lower-income countries with challenging living conditions, promises of effective artificial 
intelligence solutions that can improve the situation could override precautionary concerns 
about the potential risks.
Opportunity costs
The opportunity costs of replacing human intelligence with artificial intelligence has implications 
for the experiences that citizens bring into the political debate and the organization of powers 
and political institutions.
Democratic deficits
Many countries do not have sufficiently high-functioning, deliberative democracies in place and 
lack the ability to adequately manage and control the precautionary risks and societal impact 
assessments of artificial intelligence.
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intelligence will likely depend on how 
intolerable the current state of affairs is 
perceived to be.
Opportunity costs
In the health-care sector, we need to 
consider the opportunity cost of not 
implementing potentially beneficial 
artificial intelligence technology.2 There 
are, however, specific opportunity costs 
of choosing artificial intelligence at the 
expense of human intelligence. The 
implementation of artificial intelligence 
in health care might gradually replace 
or complement functions previously 
performed by human intelligence, such 
as exercising clinical judgement and 
providing assistance for those who need 
the help of others. The consequences for 
the workforce due to such replacement 
must be considered on the path to the 
SDGs. The input of human judgement 
will move further up the chain of deci-
sion-making, even when the EU’s ethi-
cal guidance is adhered to and artificial 
intelligence is overseen and controlled 
by human beings. The developers and 
managers of artificial intelligence will 
therefore become the authorities on the 
value and trade-offs involved in artificial 
intelligence decisions. This transition 
into a more centralized control of health 
care might create less autonomy for the 
remaining health-care professionals and 
thus negatively impact their own health. 
Moreover, if human-to-human interac-
tions are replaced by human-to-artificial 
intelligence interactions, opportunities 
for the valuable, health-promoting 
benefits of human interactions, such as 
emotional intimacy, reassurance and af-
firmation of self-worth through others, 
will decrease.
Another concern is that a decrease 
in the health-care workforce means 
having fewer people (as stakeholders) 
who can feed their experiences with 
fellow humans’ social and health-care 
needs into processes of public, political 
deliberation. Open democratic discus-
sions are important safeguards against 
the undesirable outcomes of artificial 
intelligence technology. A feedback loop 
is therefore created wherein increasing 
implementation of artificial intelligence 
methods leads to even weaker safe-
guards. Loss of the educated workforce 
in health (and other sectors) means 
that the key elements of the deliberative 
process to establish safety mechanisms 
for artificial intelligence technologies 
can therefore be lost.
All the above are potential oppor-
tunity costs of implementing artificial 
intelligence at the expense of a work-
force that is driven by individual human 
judgement. Such lost opportunities must 
be identified and discussed as part of 
a global, self-reflective, trustworthy 
artificial intelligence strategy. This is in 
addition to the risks discussed in the 
EU’s expert group report.
Democratic deficits
The EU expert group’s guidance on 
trustworthy artificial intelligence is 
based on the assumptions that high-
functioning democracies and societies 
are present to administer and counteract 
or control any undesirable outcomes 
of artificial intelligence systems. A 
potential challenge, however, is that 
these safeguarding mechanisms and 
governing powers may not be in place 
in all countries. Also, how best to or-
ganize stakeholder involvement in the 
health sector is still being debated19,20 
and current deliberations over artificial 
intelligence could be a new path for 
developing such governing institutions. 
Developing safety mechanisms based on 
particular cultural and social traditions 
for organizing and managing political 
issues would, however, be a time-con-
suming process. The development of 
artificial intelligence and the forces that 
drive it cannot be slowed to the pace of 
these deliberations.
A related, structural danger (which 
is not unique to artificial intelligence) is 
that the impact of artificial intelligence 
technology developed without safety 
restrictions in one country might affect 
other countries. An artificial intelligence 
health tool that would not even be con-
sidered in the design laboratory of one 
society could, however, be placed on the 
agenda of policy-making debates simply 
because it exists as an available option 
elsewhere.
A global approach
The artificial intelligence industry is 
driven by strong economic and political 
interests. Gaining trustworthy control 
over the potential risks and harms re-
lated to artificial intelligence is therefore 
crucial. The EU expert group’s frame-
work is designed to translate general 
principles into more concrete guidance 
and recommendations for how to ad-
dress artificial intelligence. However, the 
framework does not address threats to 
the attainment of trustworthy artificial 
intelligence embedded in real-world 
interests and complex circumstances. 
Securing the governance of trustwor-
thy artificial intelligence technologies, 
locally and globally, in health and 
other sectors, will have to be based on 
an expanded understanding of what 
translation of ethical norms into practice 
requires by addressing and managing 
structural concerns as those we have 
identified.
More concretely, there is a need for 
transnational development of shared, 
explicitly articulated rules that are 
context-independent, rather than for a 
framework that is too context-specific, 
at least before there has been a chance 
to develop local, protected political in-
stitutions. Low-income nations might 
be deterred from implementing cost–ef-
fective, but potentially unsafe artificial 
intelligence technologies to solve their 
short-term problems. As part of a 
global endeavour, high-income nations 
bear a responsibility to compensate for 
the potential losses to these countries, 
for example by financially supporting 
education of a scaled-up workforce 
of health-care personnel. The sector-
specific challenges, as pointed out by 
the EU’s report and highlighted by our 
analysis, mean that targeted translation 
of shared general principles into specific, 
global regulations could guard against 
the potential dangers of artificial intel-
ligence-based technology. The World 
Health Organization, together with the 
other UN bodies, is well-placed in the 
field of health, to lead such shared efforts 
towards globally trustworthy artificial 
intelligence. ■
Competing interests: None declared.
261Bull World Health Organ 2020;98:257–262| doi: http://dx.doi.org/10.2471/BLT.19.237289
Policy & practice



















Garantir la fiabilité de l'intelligence artificielle dans le secteur de la santé
L'intelligence artificielle regorge de potentiel en matière d'interventions 
préventives et curatives précises, efficaces et bénéfiques. Mais par la 
même occasion, elle présente certains risques et peut s'avérer nocive 
si son développement n'est pas encadré par des règles. Partout dans 
le monde, des principes directeurs sont instaurés afin de promouvoir 
un niveau de fiabilité optimal dans l'évolution et l'application des 
systèmes basés sur l'intelligence artificielle. Ces principes peuvent 
aider les développeurs et les autorités gouvernementales à prendre 
des décisions relatives à l'intelligence artificielle. Le Groupe d'experts 
de haut niveau sur l'intelligence artificielle créé par la Commission 
européenne a récemment publié un rapport intitulé Lignes directrices 
en matière d'éthique pour une IA digne de confiance. Objectif de ce 
rapport : contribuer aux réflexions et discussions portant sur l'éthique 
des technologies fondées sur l'intelligence artificielle, y compris dans les 
pays n'appartenant pas à l'Union européenne (UE). Dans ce document, 
nous utilisons le secteur mondial de la santé comme exemple et 
estimons que les directives de l'UE accordent un pouvoir discrétionnaire 
trop important aux autorités locales et au contexte pour véritablement 
encourager la fiabilité de l'intelligence artificielle dans le monde. Nous 
insistons également sur l'urgence de mettre en place une protection 
globale commune contre les éventuels préjudices liés aux technologies 
d'intelligence artificielle dans le domaine des soins de santé.
Резюме
Как обеспечить надежное и безопасное использование искусственного интеллекта в сфере 
здравоохранения
Искусственный интеллект открывает большие перспективы 
для имеющих практическую значимость, точных и эффективных 
мероприятий по профилактике и лечению заболеваний. В то же 
самое время необходимо принимать во внимание потенциальные 
риски и вред, которые могут быть вызваны нерегулируемым 
развитием искусственного интеллекта. В настоящее время идет 
процесс глобальной разработки руководящих принципов, 
способствующих надежному и безопасному формированию 
и применению систем искусственного интеллекта. Данные 
рекомендации помогут разработчикам и руководящим органам в 
принятии решений относительно использования искусственного 
интеллекта. Созданная Европейской комиссией экспертная 
группа высокого уровня по искусственному интеллекту недавно 
выпустила отчет, озаглавленный «Этические рекомендации 
для надежного и безопасного использования искусственного 
интеллекта». Цель отчета — содействие процессу анализа 
и обсуждения этической стороны применения технологий 
искусственного интеллекта за пределами Европейского 
союза (ЕС). В этой статье авторы рассматривают в качестве 
примера сектор общественного здравоохранения и доказывают, 
что рекомендации ЕС предоставляют слишком большую свободу 
действий на локальном уровне в контексте имеющихся условий, 
что препятствует обеспечению надежного использования 
искусственного интеллекта во всем мире. Авторы подчеркивают 
настоятельную необходимость совместных глобальных усилий по 
защите от потенциального вреда, который может быть нанесен 
сфере здравоохранения в результате использования технологий 
искусственного интеллекта.
ملخص
كيفية حتقيق ذكاء اصطناعي جدير بالثقة للصحة
جيمل الذكاء االصطناعي بني طياته وعودًا مجة فيام يتعلق بالتدخالت 
ذاته،  الوقت  ويف  والفعالة.  والدقيقة  املفيدة  والعالجية  الوقائية 
هناك أيًضا وعي باملخاطر واألرضار املحتملة التي قد حتدث بسبب 
التطورات غري املنظمة للذكاء االصطناعي. يتم حاليًا تطوير مبادئ 
أنظمة  وتطبيق  بالثقة،  جديرة  تنمية  لتعزيز  العامل  حول  توجيهية 
املطورين  تدعم  أن  اإلرشادات  هلذه  يمكن  االصطناعي.  الذكاء 
الذكاء  استخدام  بشأن  القرارات  اختاذ  عند  احلاكمة  والسلطات 
االصطناعي  الذكاء  خرباء  جمموعة  مؤخرًا  قامت  االصطناعي. 
تقرير  بإصدار  املفوضية األوروبية،  التي أسستها  املستوى،  رفيعي 
اجلدير  االصطناعي  للذكاء  األخالقية  التوجيهية  املبادئ  بعنوان 
اخلاصة  واملناقشة  األفكار  يف  املسامهة  إىل  التقرير  هيدف  بالثقة. 
بأخالقيات تقنيات الذكاء االصطناعي كذلك خارج دول االحتاد 
الصحة  قطاع  نستخدم  نحن  الورقة،  هذه  ويف   .(EU) األورويب 
العاملي كحالة، ونؤمن بأن توجيهات االحتاد األورويب ترتك جمااًل 
جدير  اصطناعيًا  ذكاًء  لتعزيز  بالسياق  مقرتن  حميل  لتقدير  كبريًا 
جهود  لبذل  امللحة  احلاجة  إىل  نشري  كام  العامل.  مستوى  عىل  بالثقة 
عاملية مشرتكة للوقاية من األرضار املحتملة لتكنولوجيات الذكاء 
االصطناعي يف الرعاية الصحية.
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Resumen
Cómo lograr una inteligencia artificial confiable para la salud
La inteligencia artificial es muy prometedora en términos de 
intervenciones preventivas y curativas beneficiosas, precisas y eficaces. 
Al mismo tiempo, también hay conciencia de los posibles riesgos y 
daños que pueden causar los desarrollos no regulados de la inteligencia 
artificial. Se están elaborando principios fundamentales en todo el 
mundo para fomentar el desarrollo y la aplicación confiables de los 
sistemas de inteligencia artificial. Estas directrices pueden servir de apoyo 
a los desarrolladores y a las autoridades gobernantes en la toma de 
decisiones sobre el uso de la inteligencia artificial. El Grupo de Expertos 
de Alto Nivel sobre Inteligencia Artificial establecido por la Comisión 
Europea ha publicado recientemente el informe Ethical guidelines for 
trustworthy artificial intelligence (Directrices éticas para una inteligencia 
artificial confiable). El informe tiene por objeto contribuir a la reflexión y 
el debate sobre la ética de las tecnologías de inteligencia artificial incluso 
más allá de los países de la Unión Europea (UE). En este documento, 
se recurre al sector sanitario mundial como caso de referencia y se 
argumenta que las directrices de la UE conceden demasiado margen a la 
discreción local y contextualizada como para fomentar una inteligencia 
artificial confiable a nivel mundial. Se destaca la urgencia de compartir 
los esfuerzos internacionales para protegerse de los posibles daños de 
las tecnologías de inteligencia artificial en la atención sanitaria.
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